• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study.

作者信息

Fatayer Hiba, O'Connell Rachel L, Bannon Finian, Coles Charlotte E, Copson Ellen, Cutress Ramsey I, Dave Rajiv V, Gardiner Matthew D, Grayson Margaret, Holcombe Christopher, Irshad Sheeba, Irwin Gareth W, O'Brien Ciara, Palmieri Carlo, Shaaban Abeer M, Sharma Nisha, Singh Jagdeep K, Whitehead Ian, Potter Shelley, McIntosh Stuart A

机构信息

Liverpool Breast Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.

Department of Breast Surgery, Royal Marsden NHS Foundation Trust, Sutton, UK.

出版信息

Br J Surg. 2022 Aug 16;109(9):800-803. doi: 10.1093/bjs/znac131.

DOI:10.1093/bjs/znac131
PMID:35543289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10364769/
Abstract
摘要

相似文献

1
Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study.早期乳腺癌新辅助化疗的当前实践及手术结果：英国NeST研究
Br J Surg. 2022 Aug 16;109(9):800-803. doi: 10.1093/bjs/znac131.
2
Medical treatment of early breast cancer. IV: neoadjuvant treatment.早期乳腺癌的医学治疗。IV：新辅助治疗。
BMJ. 2006 Jan 28;332(7535):223-4. doi: 10.1136/bmj.332.7535.223.
3
[Significance and specifics of surgical treatment in locally advanced breast cancer].[局部晚期乳腺癌手术治疗的意义与特点]
Vopr Onkol. 2011;57(5):578-83.
4
[Option of the surgical mode for breast cancer based on the effect of neoadjuvant chemotherapy].基于新辅助化疗效果的乳腺癌手术方式选择
Nihon Geka Gakkai Zasshi. 2002 Nov;103(11):803-5.
5
Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapy.新辅助全身治疗后的保乳手术及前哨淋巴结活检
Breast. 2009 Oct;18 Suppl 3:S90-2. doi: 10.1016/S0960-9776(09)70281-4.
6
Breast-conserving surgery after neoadjuvant chemotherapy in patients with locally advanced cancer. Preliminary results.局部晚期癌症患者新辅助化疗后保乳手术。初步结果。
G Chir. 2013 Sep-Oct;34(9-10):254-6.
7
Neoadjuvant chemotherapy in the treatment of breast cancer.新辅助化疗在乳腺癌治疗中的应用。
Surg Clin North Am. 2013 Apr;93(2):493-9. doi: 10.1016/j.suc.2013.01.006. Epub 2013 Feb 11.
8
[Breast carcinoma. Preoperative chemotherapy can preserve the breast].[乳腺癌。术前化疗可保留乳房]
MMW Fortschr Med. 2002 Oct 17;144(42):63.
9
Editorial on "Neoadjuvant Chemotherapy Does Not Increase Complications in Oncoplastic Breast-Conserving Surgery".关于“新辅助化疗不会增加肿瘤整形保乳手术并发症”的社论
Ann Surg Oncol. 2019 Sep;26(9):2655-2656. doi: 10.1245/s10434-019-07424-6. Epub 2019 May 7.
10
The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making.NeST（乳腺癌新辅助全身治疗）研究：英国多学科决策的全国实践问卷调查。
BMC Cancer. 2021 Jan 22;21(1):90. doi: 10.1186/s12885-020-07757-6.

引用本文的文献

1
Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project.局部区域新辅助全身治疗乳腺癌临床试验结局核心集制定和报告指南的制定方案：PRECEDENT 项目。
BMJ Open. 2024 Apr 19;14(4):e084488. doi: 10.1136/bmjopen-2024-084488.
2
Case report: Primary CDK4/6 inhibitor and endocrine therapy in locally advanced breast cancer and its effect on gut and intratumoral microbiota.病例报告：原发性CDK4/6抑制剂与内分泌治疗在局部晚期乳腺癌中的应用及其对肠道和肿瘤内微生物群的影响
Front Oncol. 2024 Mar 27;14:1360737. doi: 10.3389/fonc.2024.1360737. eCollection 2024.
3

本文引用的文献

1
The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making.NeST（乳腺癌新辅助全身治疗）研究：英国多学科决策的全国实践问卷调查。
BMC Cancer. 2021 Jan 22;21(1):90. doi: 10.1186/s12885-020-07757-6.
2
How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?现代新辅助化疗使多少患者降期至保乳手术？
Ann Surg Oncol. 2021 Jan;28(1):287-294. doi: 10.1245/s10434-020-08593-5. Epub 2020 Jun 8.
3
The NeST (neoadjuvant systemic therapy in breast cancer) study - Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer.
Nodal positivity in patients with clinically and radiologically node-negative breast cancer treated with neoadjuvant chemotherapy: multicentre collaborative study.
新辅助化疗治疗临床和影像学淋巴结阴性乳腺癌患者的淋巴结阳性：多中心协作研究。
Br J Surg. 2024 Jan 3;111(1). doi: 10.1093/bjs/znad401.
4
Neoadjuvant systemic therapy for breast cancer.乳腺癌新辅助全身治疗
Br J Surg. 2023 Jun 12;110(7):765-772. doi: 10.1093/bjs/znad103.
5
Predictors of surgery choices in women with early-stage breast cancer in China: a retrospective study.中国早期乳腺癌女性手术选择的预测因素：一项回顾性研究。
BMC Cancer. 2023 Jan 6;23(1):23. doi: 10.1186/s12885-023-10510-4.
NeST（乳腺癌新辅助全身治疗）研究——一项前瞻性多中心队列研究方案，旨在评估乳腺癌新辅助全身治疗的当前应用情况和短期疗效。
Int J Surg Protoc. 2019 Nov 11;18:5-11. doi: 10.1016/j.isjp.2019.10.002. eCollection 2019.
4
Multicentre prospective observational study evaluating recommendations for mastectomy by multidisciplinary teams.多中心前瞻性观察研究评估多学科团队对乳房切除术的建议。
Br J Surg. 2020 Feb;107(3):227-237. doi: 10.1002/bjs.11383. Epub 2019 Nov 5.
5
Axillary Surgery Following Neoadjuvant Chemotherapy - Multidisciplinary Guidance From the Association of Breast Surgery, Faculty of Clinical Oncology of the Royal College of Radiologists, UK Breast Cancer Group, National Coordinating Committee for Breast Pathology and British Society of Breast Radiology.新辅助化疗后的腋窝手术 - 来自英国放射科皇家学院临床肿瘤学学院、英国乳腺癌小组、国家乳腺癌病理协调委员会和英国乳腺放射学会的乳腺外科协会的多学科指导。
Clin Oncol (R Coll Radiol). 2019 Sep;31(9):664-668. doi: 10.1016/j.clon.2019.05.021. Epub 2019 Jun 19.
6
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.在三阴性乳腺癌（BrighTNess）中，将 PARP 抑制剂 veliparib 联合卡铂或卡铂单药添加到标准新辅助化疗中：一项随机、3 期试验。
Lancet Oncol. 2018 Apr;19(4):497-509. doi: 10.1016/S1470-2045(18)30111-6. Epub 2018 Feb 28.
7
Current margin practice and effect on re-excision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast-conserving therapy in the UK and Ireland.SSO-ASTRO共识和ABS共识指南发布后当前的切缘实践及其对再次切除率的影响：一项针对英国和爱尔兰2858名接受保乳治疗女性的全国性前瞻性研究。
Eur J Cancer. 2017 Oct;84:315-324. doi: 10.1016/j.ejca.2017.07.032. Epub 2017 Aug 30.
8
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.新辅助化疗后与残留癌负荷及乳腺癌亚型相关的长期预后风险
J Clin Oncol. 2017 Apr 1;35(10):1049-1060. doi: 10.1200/JCO.2015.63.1010. Epub 2017 Jan 30.
9
Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity?现代乳腺癌新辅助治疗后的保乳治疗：我们正在错失良机吗？
Eur J Surg Oncol. 2016 Dec;42(12):1780-1786. doi: 10.1016/j.ejso.2016.10.011. Epub 2016 Oct 29.
10
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.新辅助化疗后前哨淋巴结阳性乳腺癌患者的前哨淋巴结手术：ACOSOG Z1071（Alliance）临床试验。
JAMA. 2013 Oct 9;310(14):1455-61. doi: 10.1001/jama.2013.278932.